Probiotic metabolites as epigenetic targets in the prevention of colon cancer.
about
Regulation of lung immunity and host defense by the intestinal microbiotaReview on Bifidobacterium bifidum BGN4: Functionality and Nutraceutical Applications as a Probiotic MicroorganismMetabiotics: One Step ahead of Probiotics; an Insight into Mechanisms Involved in Anticancerous Effect in Colorectal CancerIdentifying molecular targets of lifestyle modifications in colon cancer prevention.Protective activity of probiotic bacteria against 2-amino-3-methyl-3H-imidazo[4,5-f]quinoline (IQ) and 2-amino-1-methyl-6-phenyl-1H-imidazo[4,5-b]pyridine (PhIP) - an in vitro study.Cellular and molecular effects of yeast probiotics on cancer.Production Conditions Affect the In Vitro Anti-Tumoral Effects of a High Concentration Multi-Strain Probiotic Preparation.A report of the frequency of colorectal carcinoma and involved lymph nodes in South-West Iran.Diet and nutrition in cancer survivorship and palliative care.Neuronal control of metabolism through nutrient-dependent modulation of tracheal branching.Bioengineered probiotics as a new hope for health and diseases: an overview of potential and prospects.Protective Effect of Lactobacillus casei on DMH-Induced Colon Carcinogenesis in Mice.Extraction of Peptidoglycan from L. paracasei subp. Paracasei X12 and Its Preliminary Mechanisms of Inducing Immunogenic Cell Death in HT-29 Cells.Apoptosis of human tongue squamous cell carcinoma cell (CAL-27) induced by Lactobacillus sp. A-2 metabolites.If microbial ecosystem therapy can change your life, what's the problem?Cell-free preparations of Lactobacillus acidophilus strain La-5 and Bifidobacterium longum strain NCC2705 affect virulence gene expression in Campylobacter jejuni.Kefir: a powerful probiotics with anticancer properties.Role of intestinal flora in colorectal cancer from the metabolite perspective: a systematic review.A novel nanomissile targeting two biomarkers and accurately bombing CTCs with doxorubicin.Time- and strain-specific downregulation of intestinal EPAS1 via miR-148a by Bifidobacterium bifidum.
P2860
Q26779232-041C82EA-5647-4C6A-AA5F-87EC7BB76D8BQ28068567-3086FBEA-AA4C-4160-834F-75CC921ED095Q28077783-D11BC087-D6F6-43B6-9A3B-AF1095EF042FQ34651881-9431CD1E-0E42-43AA-BE11-75EE81850235Q35752102-010C5D26-CF1D-4CB9-BA68-13022456CEC6Q36113199-CE925ADF-E307-42DE-BF86-C9A9E7C3213DQ36140994-DF1C09C1-8C5D-43FA-A886-7340707124B4Q36696374-5501A5E3-7DDF-49C1-8930-FEDAB5F2B30EQ37322307-BFD28219-BCE6-4267-A2BA-C0B5650D7873Q37503510-53D7CAB3-48E8-4969-A8E7-BAC44039A03DQ38806283-3994A1A2-87B8-46BA-BA3A-9612EF6EC354Q38896114-9E8886E1-9F68-44C4-9831-17EDF04D1B03Q41850496-FC84C686-8964-425B-9477-6CB8AE7DA086Q42040131-F54904D9-D373-4C13-8174-474D2A15F9F2Q42267190-0D90594B-9E42-4FEE-87B3-90086CC9EB82Q44928435-DA138EFC-E91F-4C08-90B6-8AB3CBBF70FFQ47866620-C15775E5-8DB6-452C-AF98-EB3963B8B118Q50024692-EDAC9F7E-5D3F-4F46-B683-7F415F742378Q50656099-321C9DC2-4FE1-4D30-9879-AC5C3B6E3825Q51046920-FCF04DE1-D25F-430E-8E1B-91EAF63F5EE5
P2860
Probiotic metabolites as epigenetic targets in the prevention of colon cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Probiotic metabolites as epigenetic targets in the prevention of colon cancer.
@en
type
label
Probiotic metabolites as epigenetic targets in the prevention of colon cancer.
@en
prefLabel
Probiotic metabolites as epigenetic targets in the prevention of colon cancer.
@en
P2093
P1433
P1476
Probiotic metabolites as epigenetic targets in the prevention of colon cancer.
@en
P2093
Ashok Kumar
Birbal Singh
Manoj Kumar
Navrinder Kaur
Rajkumar Hemalatha
Ravinder Nagpal
Sanjeev K Gautam
Vinod Verma
P356
10.1111/J.1753-4887.2012.00542.X
P577
2012-11-09T00:00:00Z